The prognostic and predictive value of Tregs and tumor immune subtypes in postmenopausal, hormone receptor-positive breast cancer patients treated with adjuvant endocrine therapy: a Dutch TEAM study analysis
Crossref DOI link: https://doi.org/10.1007/s10549-015-3269-7
Published Online: 2015-01-24
Published Print: 2015-02
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Engels, C. C.
Charehbili, A.
van de Velde, C. J. H.
Bastiaannet, E.
Sajet, A.
Putter, H.
van Vliet, E. A.
van Vlierberghe, R. L. P.
Smit, V. T. H. B. M.
Bartlett, J. M. S.
Seynaeve, C.
Liefers, G. J.
Kuppen, P. J. K.
License valid from 2015-01-24